TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,260 | +50.2% | 840 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $839 | -58.0% | 840 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | 0.0% | 840 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 840 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $2,000 | -50.0% | 840 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $4,000 | -63.6% | 840 | -37.1% | 0.00% | -62.5% |
| Q3 2021 | $11,000 | -35.3% | 1,335 | +28.4% | 0.01% | -33.3% |
| Q2 2021 | $17,000 | -29.2% | 1,040 | -5.9% | 0.01% | -36.8% |
| Q1 2021 | $24,000 | – | 1,105 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |